Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis
Description
CONCLUSION: Post-COVID-19 pulmonary fibrosis is a challenging consequence of COVID-19, and our case suggests that pirfenidone may be an effective treatment option.
